ES2061700T3 - Vacunas. - Google Patents
Vacunas.Info
- Publication number
- ES2061700T3 ES2061700T3 ES88312203T ES88312203T ES2061700T3 ES 2061700 T3 ES2061700 T3 ES 2061700T3 ES 88312203 T ES88312203 T ES 88312203T ES 88312203 T ES88312203 T ES 88312203T ES 2061700 T3 ES2061700 T3 ES 2061700T3
- Authority
- ES
- Spain
- Prior art keywords
- vaccines
- valent
- pathogens
- organisms
- aromatic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 239000000427 antigen Substances 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
SE PREVEE UN MICROORGANISMO ATENUADO QUE POSEE DOS GENES MUTANTES, CADA UNO DE LOS CUALES SE SITUA EN LA ZONA DEL ORGANISMO AROMATICO. ESTOS ORGANISMOS PUEDEN SER UTILES COMO BASE DE VACUNA. SE PUEDEN INGENIAR GENETICAMENTE COMO PARA EXPRESAR ANTIGENOS DE OTROS PATOGENOS Y ASI DE BASE DE UN PROMEDIO DE VACUNAS MULTI - VALENTE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878730037A GB8730037D0 (en) | 1987-12-23 | 1987-12-23 | Vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2061700T3 true ES2061700T3 (es) | 1994-12-16 |
Family
ID=10628973
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES88312203T Expired - Lifetime ES2061700T3 (es) | 1987-12-23 | 1988-12-22 | Vacunas. |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0322237B1 (es) |
JP (1) | JP2602970B2 (es) |
KR (1) | KR970010759B1 (es) |
AT (1) | ATE103331T1 (es) |
AU (1) | AU619519B2 (es) |
BR (1) | BR8807376A (es) |
CA (1) | CA1327331C (es) |
DE (1) | DE3888652T2 (es) |
DK (1) | DK174952B1 (es) |
ES (1) | ES2061700T3 (es) |
GB (1) | GB8730037D0 (es) |
HK (1) | HK1000469A1 (es) |
HU (2) | HUT55242A (es) |
IE (1) | IE65176B1 (es) |
IL (1) | IL88766A (es) |
MY (1) | MY104367A (es) |
NZ (1) | NZ227472A (es) |
PH (1) | PH31428A (es) |
RU (1) | RU2114172C1 (es) |
WO (1) | WO1989005856A1 (es) |
ZA (1) | ZA889605B (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU626139B2 (en) * | 1989-01-12 | 1992-07-23 | Commonwealth Scientific And Industrial Research Organisation | Avirulent salmonella vaccine |
IE61635B1 (en) * | 1990-03-13 | 1994-11-16 | Trinity College Dublin | Improvements in vaccines |
GB9007194D0 (en) * | 1990-03-30 | 1990-05-30 | Wellcome Found | Live vaccines |
PL170938B1 (pl) * | 1991-03-05 | 1997-02-28 | Wellcome Found | Sposób wytwarzania szczepionki przeciwko infekcjom Salmonella PL PL |
TW201794B (es) * | 1991-05-03 | 1993-03-11 | American Cyanamid Co | |
WO1994019482A1 (en) * | 1993-02-22 | 1994-09-01 | The General Hospital Corporation | Heterologous antigens in live cell vaccine strains |
AU7410798A (en) * | 1996-11-29 | 1998-06-22 | General Hospital Corporation, The | Heterologous antigens in live cell V |
GB9711964D0 (en) * | 1997-06-09 | 1997-08-06 | Medical Res Council | Live attenuated vaccines |
WO1999013053A1 (en) | 1997-09-10 | 1999-03-18 | Vion Pharmaceuticals, Inc. | Genetically modified tumor-targeted bacteria with reduced virulence |
US6080849A (en) | 1997-09-10 | 2000-06-27 | Vion Pharmaceuticals, Inc. | Genetically modified tumor-targeted bacteria with reduced virulence |
EP0913480A3 (en) * | 1997-11-03 | 2001-07-11 | Smithkline Beecham Corporation | Chorismate synthase |
US6905691B1 (en) | 1997-12-11 | 2005-06-14 | Celltech Pharma Europe Limited | Vaccines containing attenuated bacteria |
GB9806449D0 (en) | 1998-03-25 | 1998-05-27 | Peptide Therapeutics Ltd | Attenuated bacteria useful in vaccines |
US6962696B1 (en) | 1999-10-04 | 2005-11-08 | Vion Pharmaceuticals Inc. | Compositions and methods for tumor-targeted delivery of effector molecules |
GB0121998D0 (en) | 2001-09-11 | 2001-10-31 | Acambis Res Ltd | Attenuated bacteria useful in vaccines |
JP4623625B2 (ja) | 2003-07-24 | 2011-02-02 | 株式会社AMBiS | ヘテロ型5量体組換えワクチン |
FR2898276B1 (fr) * | 2006-03-08 | 2008-07-25 | Univ Claude Bernard Lyon | Nouveaux vaccins destines au traitement ou a la prevention des infections par parasites de la famille des taenidae et en particulier du genre echinococcus |
WO2012085642A1 (en) * | 2010-12-22 | 2012-06-28 | Intervet International Bv | Vaccines with live bacterial isolates for systemic administration |
WO2012123269A1 (en) | 2011-03-11 | 2012-09-20 | Proyecto De Biomedicina Cima, S.L. | Immunogenic compositions and methods for their use |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4337314A (en) * | 1979-05-23 | 1982-06-29 | Research Corporation | Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype |
US4735801A (en) * | 1982-09-07 | 1988-04-05 | Board Of Trustees Of Leland Stanford Jr. University | Novel non-reverting salmonella live vaccines |
-
1987
- 1987-12-23 GB GB878730037A patent/GB8730037D0/en active Pending
-
1988
- 1988-12-22 JP JP1501160A patent/JP2602970B2/ja not_active Expired - Lifetime
- 1988-12-22 EP EP88312203A patent/EP0322237B1/en not_active Expired - Lifetime
- 1988-12-22 HU HU89702A patent/HUT55242A/hu unknown
- 1988-12-22 HU HU89702A patent/HU216449B/hu unknown
- 1988-12-22 KR KR1019880017199A patent/KR970010759B1/ko not_active IP Right Cessation
- 1988-12-22 AU AU29193/89A patent/AU619519B2/en not_active Expired
- 1988-12-22 DE DE3888652T patent/DE3888652T2/de not_active Expired - Lifetime
- 1988-12-22 AT AT88312203T patent/ATE103331T1/de not_active IP Right Cessation
- 1988-12-22 PH PH37971A patent/PH31428A/en unknown
- 1988-12-22 NZ NZ227472A patent/NZ227472A/en unknown
- 1988-12-22 ES ES88312203T patent/ES2061700T3/es not_active Expired - Lifetime
- 1988-12-22 IL IL8876688A patent/IL88766A/en unknown
- 1988-12-22 ZA ZA889605A patent/ZA889605B/xx unknown
- 1988-12-22 RU SU4742131A patent/RU2114172C1/ru active
- 1988-12-22 MY MYPI88001526A patent/MY104367A/en unknown
- 1988-12-22 IE IE383988A patent/IE65176B1/en not_active IP Right Cessation
- 1988-12-22 CA CA000586868A patent/CA1327331C/en not_active Expired - Lifetime
- 1988-12-22 BR BR888807376A patent/BR8807376A/pt not_active Application Discontinuation
- 1988-12-22 WO PCT/GB1988/001143 patent/WO1989005856A1/en unknown
-
1989
- 1989-08-22 DK DK198904126A patent/DK174952B1/da not_active IP Right Cessation
-
1997
- 1997-10-15 HK HK97101924A patent/HK1000469A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2919389A (en) | 1989-07-19 |
AU619519B2 (en) | 1992-01-30 |
ZA889605B (en) | 1990-08-29 |
GB8730037D0 (en) | 1988-02-03 |
CA1327331C (en) | 1994-03-01 |
EP0322237A1 (en) | 1989-06-28 |
ATE103331T1 (de) | 1994-04-15 |
MY104367A (en) | 1994-03-31 |
DK174952B1 (da) | 2004-03-22 |
EP0322237B1 (en) | 1994-03-23 |
IE65176B1 (en) | 1995-10-04 |
IE883839L (en) | 1989-06-23 |
BR8807376A (pt) | 1990-03-20 |
JPH02502785A (ja) | 1990-09-06 |
HU216449B (hu) | 1999-06-28 |
DE3888652T2 (de) | 1994-07-07 |
DK412689A (da) | 1989-08-22 |
KR970010759B1 (ko) | 1997-06-30 |
KR890010200A (ko) | 1989-08-07 |
PH31428A (en) | 1998-11-03 |
DK412689D0 (da) | 1989-08-22 |
WO1989005856A1 (en) | 1989-06-29 |
JP2602970B2 (ja) | 1997-04-23 |
RU2114172C1 (ru) | 1998-06-27 |
NZ227472A (en) | 1992-07-28 |
HK1000469A1 (en) | 1998-03-27 |
DE3888652D1 (de) | 1994-04-28 |
HUT55242A (en) | 1991-05-28 |
HU890702D0 (en) | 1991-01-28 |
IL88766A (en) | 1995-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2061700T3 (es) | Vacunas. | |
NO891842L (no) | Analoger til bordetella toksinunderenhet utvunnet ved hjelp av rekombinant dna. | |
ES2098029T3 (es) | Vacunas de hepatitis que contienen monofosforil lipido a 3-o-desacilado. | |
GB2210557B (en) | Vaccine containing tumor antigens and refined detoxified endotoxin as an adjuvant. | |
ATE149841T1 (de) | Impfstoffe gegen krebs und infektionskrankheiten | |
LU91155I2 (fr) | Combinaison d'anatoxine diphtérique, d'anatoxine tétanique, d'anatoxine coquelucheuse, d'hémagglutininine filamenteuse, de pertactine, d'agglutinogènes fimbriaux coquelucheux 2 et 3 et de virus poliomyélitique inactivé type 1, type 2 et type 3. | |
YU46552B (sh) | Postupak za dobijanje vakcine protiv mycoplasme | |
MD960213A (ro) | Prepararea vaccinurilor | |
NO870123L (no) | Mastittvaksine. | |
DE3784397D1 (de) | Lebendvaccine fuer ansteckungskrankheiten von kueken. | |
GB2227936A (en) | Vaccine against brucella abortus | |
IL67818A (en) | Vaccines comprising ozone inactivated viruses and their production | |
ATE83929T1 (de) | Schweinenierenzellkultur und ihre verwendung fuer die herstellung von vakzinen. | |
KR830005871A (ko) | 광견병 백신의 제조방법 | |
ES2059479T3 (es) | Procedimiento para preparar pregneno-oxazolinas. | |
JPS5519271A (en) | Herpes virus vaccine | |
BR9809974A (pt) | Vacinas vivas atenuadas | |
SU1248281A1 (ru) | Штамм pseudomonas pseudomallei btc-57576-37 his glu asp, используемый в качестве универсального реципиента для картирования хромосомы pseudomonas pseudomallei и идентификации псевдомонад |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 322237 Country of ref document: ES |